Physician profile
Erin Wallace
NPI 1649272378
$3,097.71
in general payments reported to CMS, 2019-2025
29 companies · $954 in 2025
The $954 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $356 · 2022: $300 · 2023: $746 · 2024: $742 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,357 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,356.60 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $385.97 | 2021-2025 | Veozah |
| Sage Therapeutics, LLC | $295.28 | 2024-2025 | Zurzuvae |
| Organon LLC | $283.94 | 2021-2025 | Nexplanon, Jada System |
| Boston Scientific Corporation | $215.60 | 2025 | Axonics |
| Sumitomo Pharma America, INC. | $206.80 | 2023-2025 | Gemtesa, Myfembree |
| Daiichi Sankyo INC. | $191.46 | 2021-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $180.03 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $166.84 | 2021-2025 | |
| Novo Nordisk INC | $164.58 | 2021-2025 | Wegovy |
| Shield Therapeutics INC | $133.18 | 2023-2024 | Accrufer |
| Amgen INC. | $98.15 | 2022-2025 | Evenity, Prolia |
| Agile Therapeutics, INC. | $95.24 | 2021-2023 | Twirla |
| Abbvie INC. | $72.10 | 2023-2025 | |
| Pfizer INC. | $71.76 | 2021-2024 | |
| Radius Health, INC. | $70.74 | 2021-2025 | Tymlos |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $63.03 | 2022-2023 | Slynd |
| Inari Medical, INC. | $55.47 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Exact Sciences Corporation | $55.00 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Coopersurgical, INC. | $47.78 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $40.81 | 2021-2022 | |
| Vivus LLC | $35.99 | 2021-2023 | Qsymia |
| Axonics, INC. | $35.10 | 2023-2024 | Axonics, Bulkamid |
| Avion Pharmaceuticals | $29.79 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $20.17 | 2025 | Gardasil 9 |
| Ethicon US, LLC | $19.82 | 2025 | Vicryl |
| Coloplast Corp | $19.43 | 2024 | |
| Millicent US INC | $16.01 | 2025 | Femlyv, Intrarosa |
| Octapharma USA, INC. | $14.42 | 2024 | Fibryga |
| Hologic Sales and Service, LLC | $13.22 | 2024 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.